Drugs / Bone Marrow Derived Mononuclear Cells
Bone Marrow Derived Mononuclear Cells
Trials 5 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT03080571 | Jul 2015 → Dec 2016 | middle cerebral artery infarction | Post Graduate Institute of Medical Education and Research, Chandigarh | Completed | No outcome recorded |
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT00869024 | Nov 2011 → Mar 2016 | heart failure | University of Minnesota | Completed | No outcome recorded |
| Phase 23 trials | ||||||
| Phase 2 | NCT03572660 | Dec 2018 → Mar 2030 expected | dilated cardiomyopathy | Barts & The London NHS Trust | Active not recruiting | No outcome recorded |
| Phase 2 | NCT02033278 | Jan 2014 → Oct 2018 | non-familial dilated cardiomyopathy | Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud | Terminated | No outcome recorded |
| Phase 2 | NCT01988584 | Nov 2013 → Feb 2018 | cerebral palsy | The University of Texas Health Science Center, Houston | Completed | No outcome recorded |
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT00539266 Comparator | Oct 2007 → Oct 2012 | intermittent vascular claudication | Leiden University Medical Center | Unknown | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 8 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | bone marrow-derived mononuclear cells | “To Evaluate the Safety, Feasibility and Clinical Outcome of Intraarterial Infusion of Bone Marrow Derived Mononuclear Cells in Subacute Ischaemic Stroke Patients” NCT03080571 ↗5“Intracoronary infusion of bone marrow-derived mononuclear cells (BMMNC) has demonstrated to improve ventricular function after acute myocardial infarction.” PMID 31438858 ↗ Aug 2019 |
| Known as | BMMNC | “Intracoronary infusion of bone marrow-derived mononuclear cells (BMMNC) has demonstrated to improve ventricular function after acute myocardial infarction.” PMID 31438858 ↗ Aug 2019 |
| Known as | BMMNCs | “undergoing intracoronary infusion of autologous bone-marrow derived mononuclear cells (BMMNCs)” PMID 40145630 ↗ Mar 20251“bone marrow derived mononuclear cells (BMMNCs)” NCT01988584 ↗ |
| Modality | Cell therapy | “cell-based strategies in no-option patients” PMID 30004916 ↗ Nov 2018 |
| Route | Intramuscular | “Concentrated cells or placebo (diluted blood) were intramuscularly injected at 40 locations of the calf muscle.” PMID 30004916 ↗ Nov 2018 |